Shantell Laketa Heiber

Array ( [id] => 7457278 [patent_doc_number] => 20040197347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Methods for vaccine identification and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the herpesvirus family' [patent_app_type] => new [patent_app_number] => 10/669161 [patent_app_country] => US [patent_app_date] => 2003-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 49661 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20040197347.pdf [firstpage_image] =>[orig_patent_app_number] => 10669161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7199595 [patent_doc_number] => 20040086527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Protecting against canine oral papillonmavirus (COPV)' [patent_app_type] => new [patent_app_number] => 10/665537 [patent_app_country] => US [patent_app_date] => 2003-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19002 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20040086527.pdf [firstpage_image] =>[orig_patent_app_number] => 10665537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7303235 [patent_doc_number] => 20040115212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Attenuated microorganism strains and their uses' [patent_app_type] => new [patent_app_number] => 10/665407 [patent_app_country] => US [patent_app_date] => 2003-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8477 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115212.pdf [firstpage_image] =>[orig_patent_app_number] => 10665407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4570829 [patent_doc_number] => 07824689 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-02 [patent_title] => 'Chicken astrovirus type 2' [patent_app_type] => utility [patent_app_number] => 10/527767 [patent_app_country] => US [patent_app_date] => 2003-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4424 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/824/07824689.pdf [firstpage_image] =>[orig_patent_app_number] => 10527767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1043421 [patent_doc_number] => 06866854 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-15 [patent_title] => 'Spliced gene of KSHV/HHV8, its promoter and monoclonal antibodies specific for LANA2' [patent_app_type] => utility [patent_app_number] => 10/656499 [patent_app_country] => US [patent_app_date] => 2003-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17790 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/866/06866854.pdf [firstpage_image] =>[orig_patent_app_number] => 10656499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 482098 [patent_doc_number] => 07220545 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-22 [patent_title] => 'Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method' [patent_app_type] => utility [patent_app_number] => 10/655855 [patent_app_country] => US [patent_app_date] => 2003-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8331 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/220/07220545.pdf [firstpage_image] =>[orig_patent_app_number] => 10655855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7208694 [patent_doc_number] => 20050053605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Methods and compositions for treating herpes infections' [patent_app_type] => utility [patent_app_number] => 10/656781 [patent_app_country] => US [patent_app_date] => 2003-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4392 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20050053605.pdf [firstpage_image] =>[orig_patent_app_number] => 10656781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7208854 [patent_doc_number] => 20050053626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Grace process biotechnology patent the cure to the herpes virus' [patent_app_type] => utility [patent_app_number] => 10/446200 [patent_app_country] => US [patent_app_date] => 2003-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 237 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20050053626.pdf [firstpage_image] =>[orig_patent_app_number] => 10446200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7380201 [patent_doc_number] => 20040081661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Papillomavirus truncated L1 protein and fusion protein constructs' [patent_app_type] => new [patent_app_number] => 10/654129 [patent_app_country] => US [patent_app_date] => 2003-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7644 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20040081661.pdf [firstpage_image] =>[orig_patent_app_number] => 10654129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 682390 [patent_doc_number] => 07081342 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-25 [patent_title] => 'Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142' [patent_app_type] => utility [patent_app_number] => 10/654545 [patent_app_country] => US [patent_app_date] => 2003-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18510 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/081/07081342.pdf [firstpage_image] =>[orig_patent_app_number] => 10654545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7251824 [patent_doc_number] => 20050074751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Assays and therapies for latent viral infection' [patent_app_type] => utility [patent_app_number] => 10/646132 [patent_app_country] => US [patent_app_date] => 2003-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13097 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20050074751.pdf [firstpage_image] =>[orig_patent_app_number] => 10646132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 478185 [patent_doc_number] => 07223594 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-29 [patent_title] => 'Circovirus sequences associated with piglet weight loss disease (PWD)' [patent_app_type] => utility [patent_app_number] => 10/637011 [patent_app_country] => US [patent_app_date] => 2003-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 30 [patent_no_of_words] => 23851 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/223/07223594.pdf [firstpage_image] =>[orig_patent_app_number] => 10637011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7133560 [patent_doc_number] => 20040043036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Complex of Hepatitis B virus polymerase with p11 and method for controlling movement of the complex in HepG2 cell' [patent_app_type] => new [patent_app_number] => 10/637602 [patent_app_country] => US [patent_app_date] => 2003-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3555 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043036.pdf [firstpage_image] =>[orig_patent_app_number] => 10637602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7288684 [patent_doc_number] => 20040109879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Method of Treating Herpes Virus Infections' [patent_app_type] => new [patent_app_number] => 10/604591 [patent_app_country] => US [patent_app_date] => 2003-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1409 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20040109879.pdf [firstpage_image] =>[orig_patent_app_number] => 10604591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 630302 [patent_doc_number] => 07132262 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-07 [patent_title] => 'Papilloma virus sequences' [patent_app_type] => utility [patent_app_number] => 10/630880 [patent_app_country] => US [patent_app_date] => 2003-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13131 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/132/07132262.pdf [firstpage_image] =>[orig_patent_app_number] => 10630880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 619602 [patent_doc_number] => 07141243 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-28 [patent_title] => 'gM-negative EHV-mutants without heterologous elements' [patent_app_type] => utility [patent_app_number] => 10/624149 [patent_app_country] => US [patent_app_date] => 2003-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13243 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/141/07141243.pdf [firstpage_image] =>[orig_patent_app_number] => 10624149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7219468 [patent_doc_number] => 20040072152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same' [patent_app_type] => new [patent_app_number] => 10/623429 [patent_app_country] => US [patent_app_date] => 2003-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 29312 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072152.pdf [firstpage_image] =>[orig_patent_app_number] => 10623429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7449267 [patent_doc_number] => 20040067533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'Method to reduce false positive outcomes in prion tests' [patent_app_type] => new [patent_app_number] => 10/620082 [patent_app_country] => US [patent_app_date] => 2003-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3948 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20040067533.pdf [firstpage_image] =>[orig_patent_app_number] => 10620082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 975315 [patent_doc_number] => 06933123 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-23 [patent_title] => 'Peptides from the E2, E6, and E7 proteins of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers' [patent_app_type] => utility [patent_app_number] => 10/612818 [patent_app_country] => US [patent_app_date] => 2003-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7181 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/933/06933123.pdf [firstpage_image] =>[orig_patent_app_number] => 10612818 [rel_patent_id] =>[rel_patent_doc_number] =>)